Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 138

    1.

    IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistance.

    Maddux BA, Chan A, De Filippis EA, Mandarino LJ, Goldfine ID.

    Diabetes Care. 2006 Jul;29(7):1535-7. Erratum in: Diabetes Care. 2006 Nov;29(11):2571. De Filippis, Elena A [added]. PMID: 16801575 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance.

    Borai A, Livingstone C, Zarif H, Ferns G.

    Ann Clin Biochem. 2009 Mar;46(Pt 2):109-13. Epub 2009 Jan 22.PMID: 19164337 [PubMed - indexed for MEDLINE]Related articles

    3.

    Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

    Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A, Gibson JM.

    Diabetologia. 2001 Mar;44(3):333-9.PMID: 11317665 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin-like growth factor binding protein-1 to screen for insulin resistance in children.

    Motaghedi R, Gujral S, Sinha S, Sison C, Ten S, Maclaren NK.

    Diabetes Technol Ther. 2007 Feb;9(1):43-51.PMID: 17316097 [PubMed - indexed for MEDLINE]Related articles

    5.

    No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance.

    Ricart W, Fernández-Real JM.

    Obes Res. 2001 Oct;9(10):631-6.PMID: 11595780 [PubMed - indexed for MEDLINE]Related articles

    6.

    Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidism.

    Jenkins RC, Valcavi R, Zini M, Frasoldati A, Heller SR, Camacho-Hubner C, Gibson JM, Westwood M, Ross RJ.

    Clin Endocrinol (Oxf). 2000 Feb;52(2):187-95.PMID: 10671946 [PubMed - indexed for MEDLINE]Related articles

    7.

    Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).

    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.

    Diabetes. 2006 Aug;55(8):2333-9.PMID: 16873698 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.

    Kotronen A, Lewitt M, Hall K, Brismar K, Yki-Järvinen H.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4867-72. Epub 2008 Sep 16.PMID: 18796514 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    IGFBP-1 levels in adult women born small for gestational age suggest insulin resistance in spite of normal BMI.

    Kistner A, Jacobson SH, Celsi G, Vanpee M, Brismar K.

    J Intern Med. 2004 Jan;255(1):82-8.PMID: 14687242 [PubMed - indexed for MEDLINE]Related articles

    10.

    Serum levels of insulin-like growth factor-I (IGF-I), and IGF-binding proteins-1 and -3 in middle-aged and young athletes versus sedentary men: relationship with glucose disposal.

    Manetta J, Brun JF, Fedou C, Maïmoun L, Prefaut C, Mercier J.

    Metabolism. 2003 Jul;52(7):821-6.PMID: 12870155 [PubMed - indexed for MEDLINE]Related articles

    11.

    A study to evaluate surrogate markers of insulin resistance in forty euglycemic healthy subjects.

    Gupta AK, Jain SK.

    J Assoc Physicians India. 2004 Jul;52:549-53.PMID: 15645980 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effects of intensive training on insulin-like growth factor I (IGF-I) and IGF binding proteins 1 and 3 in competitive cyclists: relationships with glucose disposal.

    Manetta J, Brun JF, Maïmoun L, Fédou C, Préfaut C, Mercier J.

    J Sports Sci. 2003 Mar;21(3):147-54.PMID: 12703844 [PubMed - indexed for MEDLINE]Related articles

    13.

    Insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein (IGFBP)-3 levels in Arab subjects with coronary heart disease.

    Akanji AO, Suresh CG, Al-Radwan R, Fatania HR.

    Scand J Clin Lab Invest. 2007;67(5):553-9.PMID: 17763192 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men.

    Liew CF, Wise SD, Yeo KP, Lee KO.

    J Clin Endocrinol Metab. 2005 Mar;90(3):1483-8. Epub 2004 Dec 14.PMID: 15598684 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin-like growth factor binding protein-1 and interleukin-6 are markers of fetal stress during parturition at term gestation.

    Marchini G, Hagenäs L, Kocoska-Maras L, Berggren V, Hansson LO.

    J Pediatr Endocrinol Metab. 2005 Aug;18(8):777-83.PMID: 16200844 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: effects of angiotensin converting enzyme inhibition.

    Laviades C, Gil MJ, Monreal I, González A, Díez J.

    J Hypertens. 1998 Jun;16(6):863-70.PMID: 9663927 [PubMed - indexed for MEDLINE]Related articles

    17.

    Low serum insulin-like growth factor-binding protein-1 is associated with an unfavourable cardiovascular risk profile in elderly men.

    Harrela M, Koistinen R, Tuomilehto J, Nissinen A, Seppälä M.

    Ann Med. 2000 Sep;32(6):424-8.PMID: 11028691 [PubMed - indexed for MEDLINE]Related articles

    18.

    A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.

    Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Ueda S, Funahashi T, Matsuzawa Y.

    Diabetes Res Clin Pract. 2007 Jul;77(1):151-4. Epub 2006 Nov 1. Erratum in: Diabetes Res Clin Pract. 2007 Sep;77(3):496. Ueda, Shinichiro [added]. PMID: 17081646 [PubMed - indexed for MEDLINE]Related articles

    19.

    Short-term administration of an angiotensin-receptor antagonist in patients with impaired fasting glucose improves insulin sensitivity and increases free IGF-I.

    Zandbergen AA, Lamberts SW, Janssen JA, Bootsma AH.

    Eur J Endocrinol. 2006 Aug;155(2):293-6.PMID: 16868143 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.

    Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):371-6.PMID: 16915540 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data